St. Paul, Minnesota-based Solventum — the 3M Healthcare spinoff — made Egeland responsible for leading its global medical and clinical affairs team.
In his role as CMO, Egeland aims to foster industry collaboration and identify innovation and market expansion opportunities. Solventum said these opportunities come at “the intersection of scientific rigor, clinical need and commercial practicality.” Egeland now reports to Chris Barry, EVP and group president of Medical Surgical at Solventum.
“We are pleased to welcome Dr. Egeland to Solventum,” Barry said. “With over two decades of experience in the research lab, operating room, and executive settings, his extensive experience and proven track record in clinical development strategy and execution will be invaluable as we advance our innovation pipeline and enhance patient care around the world.”
Egeland joins from Crossfire Medical, where he became CEO in 2022. The company develops novel thermal and non-thermal devices for the chronic venous insufficiency (CVI) market.
Previously, he held the role of head of strategic ventures and chief medical officer for Cardiovascular Systems (CSI). Abbott acquired CSI last year. Before CSI, he led teams in business development & licensing, medical and scientific affairs and product marketing at Medtronic, Covidien and ev3.
Egeland is also a trained plastic and reconstructive surgeon.
“I am thrilled to join Solventum. With products that offer profound clinical benefits and solutions that enhance provider efficiency and impact, we have a rare opportunity to help our customers enhance the patient experience and improve lives,” said Egeland. “Through partnership, innovation, and dedication to the patients we serve Solventum and our customers, together, will shape the future of healthcare.”